Clearside Biomedical Inc (NASDAQ:CLSD)’s traded shares stood at 0.49 million during the last session, with the company’s beta value hitting 2.30. At the close of trading, the stock’s price was $1.45, to imply an increase of 9.02% or $0.12 in intraday trading. The CLSD share’s 52-week high remains $2.12, putting it -46.21% down since that peak but still an impressive 55.17% since price per share fell to its 52-week low of $0.65. The company has a valuation of $108.39M, with an average of 0.41 million shares in intraday trading volume over the past 10 days and average of 277.35K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Clearside Biomedical Inc (CLSD), translating to a mean rating of 1.00. Of 5 analyst(s) looking at the stock, 0 analyst(s) give CLSD a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 5 recommend it as a Buy.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Clearside Biomedical Inc (NASDAQ:CLSD) trade information
After registering a 9.02% upside in the last session, Clearside Biomedical Inc (CLSD) has traded red over the past five days. The 5-day price performance for the stock is 25.00%, and 56.35% over 30 days. With these gigs, the year-to-date price performance is 23.93%. Short interest in Clearside Biomedical Inc (NASDAQ:CLSD) saw shorts transact 0.27 million shares and set a 0.8 days time to cover.
Clearside Biomedical Inc (CLSD) estimates and forecasts
Looking at statistics comparing Clearside Biomedical Inc share performance against respective industry, we note that the company has underperformed competitors. Clearside Biomedical Inc (CLSD) shares are 11.54% up over the last 6 months, with its year-to-date growth rate lower than industry average at -5.66% against 17.60%.
CLSD Dividends
Clearside Biomedical Inc has its next earnings report out on 2024-Nov-11. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Clearside Biomedical Inc (NASDAQ:CLSD)’s Major holders
Clearside Biomedical Inc insiders hold 7.39% of total outstanding shares, with institutional holders owning 26.33% of the shares at 28.43% float percentage. In total, 26.33% institutions holds shares in the company, led by VANGUARD GROUP INC. As of 2024-06-30, the company held over 2.84 million shares (or 4.0656% of shares), all amounting to roughly $3.69 million.
The next major institution holding the largest number of shares is ROSALIND ADVISORS, INC. with 2.59 million shares, or about 3.7115% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $3.37 million.
